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Abstract
An extensive body of evidence indicates that oxidative stress and inflammation play a central role in the degenerative
changes of systemic tissues in aging. However a comparatively limited amount of data is available to verify whether these
processes also contribute to normal aging within the brain. High levels of oxidative damage results in key cellular changes
including a reduction in available nicotinamide adenine dinucleotide (NAD+), an essential molecule required for a number of
vital cellular processes including DNA repair, immune signaling and epigenetic processing. In this study we quantified
changes in [NAD(H)] and markers of inflammation and oxidative damage (F2-isoprostanes, 8-OHdG, total antioxidant
capacity) in the cerebrospinal fluid (CSF) of healthy humans across a wide age range (24–91 years). CSF was collected from
consenting patients who required a spinal tap for the administration of anesthetic. CSF of participants aged .45 years was
found to contain increased levels of lipid peroxidation (F2-isoprostanes) (p = 0.04) and inflammation (IL-6) (p = 0.00) and
decreased levels of both total antioxidant capacity (p = 0.00) and NAD(H) (p = 0.05), compared to their younger
counterparts. A positive association was also observed between plasma [NAD(H)] and CSF NAD(H) levels (p = 0.03). Further
analysis of the data identified a relationship between alcohol intake and CSF [NAD(H)] and markers of inflammation. The CSF
of participants who consumed .1 standard drink of alcohol per day contained lower levels of NAD(H) compared to those
who consumed no alcohol (p,0.05). An increase in CSF IL-6 was observed in participants who reported drinking .0–1
(p,0.05) and .1 (p,0.05) standard alcoholic drinks per day compared to those who did not drink alcohol. Taken together
these data suggest a progressive age associated increase in oxidative damage, inflammation and reduced [NAD(H)] in the
brain which may be exacerbated by alcohol intake.
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Introduction
Aging is an unavoidable biological process characterized by a
progressive decline in physiological and biochemical function
resulting in an increased predisposition to disease. In 1956
Harman proposed the oxidative stress theory of aging suggesting
that the accumulation of unrepaired oxidative damage results in
the typical aging phenotype [1]. The term ‘oxidative stress’
describes a significant imbalance between antioxidant defenses
and the bodies’ formation of reactive nitrogen and/or oxygen
species (ROS). While there are several sources of ROS within the
body, the primary source is generally agreed to be the leakage of
electrons to ground state oxygen from early components of the
mitochondrial electron transport chain, resulting in the production
of the superoxide radical (O2
N–) [2,3]. Importantly, at modest
concentrations, ROS are used in a variety of normal physiological
functions. Although there is the potential for damage, this is kept
in check by an intricately connected antioxidant defense and
repair system [4]. However, under conditions of reduced
antioxidant capacity or excess production, ROS can cause
indiscriminant damage to cellular constituents (DNA, proteins
and lipids) that, if unrepaired, may lead to cell death and tissue
dysfunction.
The brain is particularly vulnerable to oxidative damage as a
consequence of its high oxygen demand, high level of both
polyunsaturated fatty acids and transition metals, and poor
antioxidant defenses [5–7]. As we age, the vulnerability of the
brain to oxidative damage increases due to reduced integrity of the
blood brain barrier and amplified mitochondrial dysfunction [8,9].
Indeed animal and tissue studies have shown the aging brain to be
accompanied by an accumulation of markers of lipid, protein and
DNA oxidative damage [10–12]. Failure to repair this damage has
been demonstrated to cause genomic instability and neuronal
apoptosis and is associated with the development of neuropathol-
ogies such as Alzheimer’s disease, Parkinson’s disease, and
amyotrophic lateral sclerosis [13–17].
Both normal brain aging and neurodegenerative disease are
characterized by increased inflammation associated with microg-
lial over activation and a subsequent rise in pro-inflammatory
cytokines [18–21]. Excessive release of pro-inflammatory cytokines
further promotes a pro-oxidative state and neuronal degradation.
Elevated levels of the inflammatory cytokine IL-6 have been
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associated with cognitive impairment and the induction of
Alzheimer’s-type hyperphosphorylation of tau protein [22,23].
As inflammation and oxidative damage rise with age a decrease
in available nicotinamide adenine dinucleotide (NAD+) has been
observed in multiple organs of the rat [24], including the brain
(data unpublished). NAD+ is a ubiquitous molecule that is required
for a number of vital cellular processes. In addition to its role in
cellular energy and metabolism there are several enzymes,
including poly(ADP-ribose) polymerase 1 (PARP) and silent
information regulators (e.g. SIRT1), that use NAD+ as their
substrate [25–27]. Importantly PARP activation in response to
DNA damage catalyzes the successive cleavage of the ADP-ribose
moiety from NAD+ resulting in the formation of poly(ADP-ribose)
subunits. Under conditions of mild-to-moderate DNA damage this
process facilitates DNA repair [28]. However over-activation of
PARP, due to excessive DNA damage, can result in neuronal
death as a consequence of decreased ATP production due to
NAD+ depletion [29–31]. In order to preserve cellular energy and
concomitantly SIRT1 (associated with maintaining cellular
longevity) and PARP activity, adequate levels of NAD+ must be
sustained.
Inflammation and oxidative activity, when adequately regulat-
ed, form part of the normal physiology in all age groups. However
during the course of life, each individual will experience (to
varying degrees) a gradual increase in oxidative damage burden in
many of the body’s tissues. If experienced in the brain,
neurodegenerative changes are likely. While age is the major risk
factor for the development of most neurodegenerative disorders
[32,33], a number of lifestyle choices can also promote pathogen-
esis by increasing oxidative stress. Previous studies have indicated
that chronic alcohol exposure in humans’ results in neurodegen-
eration, ranging from minor synaptic and dendritic changes to
neuronal cell death [34]. More recently administration of alcohol
to rats was shown to significantly increase brain mitochondrial
lipid and protein oxidation and decrease superoxide dismutase
mRNA expression and ATP-ase activity. The authors postulated
that the alcohol-induced production of ROS alters mitochondrial
membrane properties leading to mitochondrial dysfunction and
subsequently further ROS production [35].
Collectively these reports indicate that certain lifestyle choices
may accelerate the development of an age associated oxidative-
inflammatory state leading to increased tissue damage and
reduced DNA repair capacity (through reduced NAD+ availability)
within the central nervous system. While evidence from cell
culture, animal and limited postmortem brain tissue studies
support this hypothesis, to date no study has investigated this in
a healthy human cohort.
In this study we investigated whether markers of oxidative and
inflammatory activity increase with age in the central nervous
system of relatively healthy humans and whether this was
associated with a decrease in available NAD(H). We further
correlated changes in CSF oxidative/inflammatory markers and
[NAD(H)] with specific modifiable lifestyle factors.
Materials and Methods
Ethics Statement
This study was conducted in accordance with the Helsinki
declaration. Ethical approval was obtained from the Human
Research Ethics Committee, Sydney Adventist Hospital (HREC#
2011-005). Written informed consent was obtained from all
participants prior to commencement.
Participants
Male (n = 20) and female (n = 50) participants, who required a
spinal tap for the administration of anesthetic as part of routine
care, were recruited at Sydney Adventist Hospital, Australia. The
average age of participants was 53 years (SD = 19.9, interquartile
range = 38). Participants were excluded from the cohort if they
were smokers or had a confirmed diagnosis of a neurological/
neurodegenerative disorder or central nervous system infection. In
total 70 CSF and 38 matched blood samples were collected from
consenting participants considered in general good health.
Sample Collection
Fasting ($10 h) blood and CSF samples were collected by an
accredited anesthetist no longer than 30 minutes apart. CSF
samples were collected, prior to injection of spinal anesthetics, via
standard lumber puncture. Blood samples were collected into
heparinized tubes from an intravenous cannula inserted into a
superficial vein on an upper limb, prior to the administration of
fluids or anesthetics. Samples were prepared by centrifuging at
1800 rpm for 10 minutes and stored within 1 hour of collection, at
2194 degrees Celsius until analysis. Samples intended for F2-
isoprostane analysis where stored in the presence of a glutathione/
butylated hydroxytoluene preservative.
Assessment of Alcohol Consumption
Alcohol consumption was assessed via questionnaire upon
hospital admission. Specifically participants were asked ‘Do you
drink alcohol.’ If this was affirmative participants were asked to
provide the number of standard drinks consumed per day.
Total NAD(H)
Total NAD(H) concentrations in plasma and CSF samples were
measured spectrophotometrically using a thiazolyl blue micro-
cycling assay established by Bernofsky and Swan (1973) [36], and
adapted to a 96 well plate format by Grant and Kapoor (1998)
[37]. In brief, 125 mL of the reaction mixture containing 120 mM
bicine (pH 7.8), 0.5 mM MTT, 2 mM PMS, 0.6 M ethanol and
alcohol dehydrogenase (300 units/mL) was added to either 6 mL
of plasma or 20 mL of CSF. Following a 10 minute incubation at
37 degrees Celsius, the concentration of total NAD(H) was
measured, using a Model 680XR microplate reader (BioRad,
Hercules), as the change in absorbance at 570 nm.
Total Antioxidant Capacity (TAC)
CSF total antioxidant capacity was measured using a standard-
ized commercial kit (Antioxidant Assay Kit, Cayman Chemical
Company, Ann Arbor, MI USA). This assay relies on the ability of
antioxidants to inhibit oxidation of 2,29-Azino-di-[3-ethylbenzthia-
zoline sulphonate] (ABTS) by metmyoglobin. Briefly, 10 mL of
metmyoglobin was added to 10 mL of diluted sample. 150 mL of
chromagen, containing ABTS, was subsequently added and the
reaction initiated by adding 40 mL of 441 mM hydrogen peroxide.
The plate was incubated on a shaker for 5 minutes and the amount
of oxidized ABTS was measured spectrophotometrically, at an
absorbance of 750 nm, using a Model 680XR microplate reader
(BioRad, Hercules).
Interleukin-6 (IL-6)
IL-6 was measured using a standardized commercial solid phase
sandwich enzyme linked-immuno-sorbent assay (ELISA) (Human
IL6 High Sensitivity ELISA Kit, Abcam, Cambridge, MA USA).
Briefly, 100 mL of CSF was added to a plate pre-coated with a
monoclonal antibody specific for IL-6. 50 mL of biotinylated anti-
CSF Oxidative Stress, Inflammation and [NAD(H)]
PLOS ONE | www.plosone.org 2 January 2014 | Volume 9 | Issue 1 | e85335
IL6 was then added and the plate incubated for 3 hours. After
incubation, the plate was washed before the addition of the
enzyme, horseradish peroxidase. The plate was incubated for 30
minutes and then washed again to remove any unbound enzymes.
The 3,39,5,59-Tetramethylbenzidine substrate was added and the
plate was incubated in the dark for 12–15 minutes, after which
H2SO4 was added to the wells to stop the enzyme-substrate
reaction. The intensity of this colored product is directly
proportional to IL-6 concentration. Absorbance was measured at
450 nm using a Model 680XR microplate reader (BioRad,
Hercules).
8-hydroxy-29-deoxyguanosine (8-OHdG)
8-OHdG was measured in CSF samples using a standardized
commercial competitive ELISA (Highly Sensitive 8-OHdG Check,
Japan Institute for the Control of Aging, Shizuoka Japan). Briefly
50 mL of sample or standard and 50 mL monoclonal antibody was
adsorbed onto a 96-well plate precoated with 8 OHdG. Following
an overnight incubation at 4 degrees Celsius the plate was washed
and incubated with a secondary antibody for 1 hour. The plate
was washed again before the addition of a chromatic solution for
15 minutes, after which the reaction was terminated and
absorbance was measured at 450 nm using a Model 680XR
microplate reader (BioRad, Hercules).
F2-Isoprostanes
Total F2-Isoprostanes were measured in CSF by gas chroma-
tography–mass spectrometry (GC-MS) using electron capture
negative ionization according to a modification in the method of
Mori et al (1999) [38]. Briefly, after the addition of an internal
standard (15-F2t-IsoP-d4, 5 ng), plasma and CSF samples
(200 mL) were hydrolyzed with KOH in methanol, acidified,
and applied to prewashed Certify II cartridges (Varian). Following
washing with methanol:water (1:1) and hexane:ethyl acetate
(75:25) the F2-Isoprostanes were eluted with ethyl acetate:metha-
nol (90:10), dried, and derivatized. The F2-Isoprostanes were
quantitated by monitoring ions at m/z 569 and 573 for F2-
Isoprostanes and 15-F2t-IsoP-d4 respectively.
Statistical Analysis
Statistical analyses were performed using SPSS version 16.0 and
GraphPad Prism version 5 for Windows. Data is presented as
means 6 standard deviation unless otherwise stated. Multiple
linear regression, controlling for age, was used to identify
significant relationships between CSF [NAD(H)], plasma
[NAD(H)], and markers of oxidative damage and inflammation.
The Independent T Test or Mann-Whitney U Test was employed
to analyze the effect of age on markers of oxidative damage,
inflammation and metabolism. The Wilcoxon Signed Ranks Test
was used to identify the association between mean plasma and
CSF NAD(H) levels. Kruskal-Wallis with Dunn’s post-hoc test was
used to assess the effect of alcohol consumption on markers of
oxidative damage, inflammation and metabolism. Both the
Kolmogorov-Smirnov, Shapiro-Wilk and histogram analysis was
used to check normality of the variables. When required the
Levene’s Test of Equality was used to check homogeneity of
variances between groups. If the variances of the groups were
found to be either not homogenous and/or normality tests for the
variables were not significant then further investigation with
graphical displays was performed to assess the distributions of the
variables. Both adjusted and non-adjusted P-values are provided
throughout with test significance set at P value #0.05.
Results
Age Associated Differences in CSF Markers of Oxidative
and Inflammation
A number of studies have shown that lifestyle behaviors in
midlife (i.e. around 45–50 years) are associated with reduced
cognitive function in later life [38–42]. Thus to assess age related
differences in CSF markers of oxidative damage and inflamma-
tion, for this analysis participants were divided into two groups,
aged #45 years and .45 years.
In this cohort older age was associated with an increase in a
number of CSF oxidative and inflammatory markers (Table 1).
Specifically CSF lipid peroxidation (F2-isoprostane) was signifi-
cantly increased in those aged .45 years; 417.49634.39 pmol/L
compared to those #45 years; 395.09634.04 pmol/L (p = 0.04).
Those over 45 years also showed significantly increased levels of
the inflammatory cytokine IL-6 (p = 0.00, 2.3761.93 vs.
0.7160.43 pg/mL for those #45 years) and reduced CSF TAC
levels (p = 0.00, 0.9060.28 vs. 1.4960.51 nmol/mg protein for
those ,45 years). Those aged .45 years also tended to have
raised levels of CSF 8-OHdG, a marker of oxidative DNA
damage, although this did not quite reach statistical significance
(p = 0.06) (Table 1).
Assessing these trends in each gender revealed that the CSF of
females .45 years contained significantly higher levels of IL-6
(p = 0.00, 1.7161.23 vs. 0.6960.43 pg/mL) and lower TAC levels
(p = 0.00, 0.9860.30 vs. 1.4960.51 nmol/mg protein) than their
younger counterparts. Due to low number of male participants
#45 years, valid comparisons were not possible.
Age Associated Decrease in CSF NAD(H)
CSF NAD(H) levels were significantly lower in participants aged
.45 years compared to those aged #45 years; 75.88630.14 vs.
88.59621.07 mg/mL respectively (p = 0.05) (Table 1). Assessing
these trends in each gender revealed that, the CSF of females .45
years contained significantly lower levels of NAD(H) compared to
their younger counterparts (p = 0.01, 73.13625.99 vs.
89.98619.75 mg/mL respectively). Due to low number of male
participants #45 years, valid comparisons were not possible.
Inter-correlation between CSF NAD(H), Oxidative
Damage and Inflammatory Markers
After controlling for age, a significant inverse association was
observed between CSF log TAC and CSF 8 OHdG (p = 0.05,
n = 37) (Figure 1A). A significant positive association was observed
between CSF DNA (8 OHdG) and lipid oxidation (F2-isoprostane)
markers (p = 0.01, n = 34) (Figure 1B). An inverse association
between CSF [NAD(H)] and F2-isoprostane levels was also found
(p = 0.02, n = 48) although this did not remain statistically
significant after controlling for age (p = 0.06) (Figure 1C). No
further associations were apparent between CSF [NAD(H)],
oxidative damage and inflammatory markers.
CSF [NAD(H)] Correlates with Peripheral [NAD(H)]
After controlling for age, a significant positive relationship was
observed between plasma and CSF NAD(H) concentrations
(p = 0.03, n = 38) (Figure 2). An increase of one mg/mL in plasma
[NAD(H)] was associated with a 0.11 mg/mL increase in CSF
[NAD(H)]. The mean level of NAD(H) was significantly lower in
CSF (82.24626.59 mg/mL, n = 38) compared to plasma
(358.81698.56 mg/mL, n = 38) (p = 0.00).
CSF Oxidative Stress, Inflammation and [NAD(H)]
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Influence of Alcohol Intake on CSF [NAD(H)], Oxidative
Damage and Inflammation
The data was further analyzed to identify possible relationships
between alcohol intake and CSF [NAD(H)] and markers of
inflammation and oxidative damage. For this analysis, participants
were divided into three groups, those who consumed zero (n = 32),
.0–1 (n = 14) and .1 (n = 8) standard alcoholic drinks per day.
CSF NAD(H) levels were significantly different between the groups
(p = 0.02). Specifically the CSF of participants who consumed .1
standard drink of alcohol per day contained significantly lower
levels of NAD(H) compared to those who reported consuming zero
drinks per day; 62.39619.93 vs. 86.93625.32 mg/mL respectively
(p,0.05) (Figure 3A). A significant increase in CSF IL-6 was also
observed in participants who drank .1 (p,0.05) and 0–1
(p,0.05) standard alcoholic drinks per day compared to those
who did not consume alcohol; 2.1161.28, 2.2561.66 vs.
1.1661.67 pg/mL respectively (Figure 3B). No associations were
found between alcohol consumption and CSF markers of DNA (8-
OHdG) and lipid (F2-isoprostanes) oxidative damage or total
antioxidant capacity. When the data was stratified according to
both age and gender CSF IL6 levels remained significantly higher
in female participants who drank .0–1 or $1 standard alcoholic
drinks per day. No other observations remained statistically
significant after stratifying for age and gender.
Gender Associated Differences in CSF Markers of
Oxidative Damage and Inflammation
In this cohort, the CSF of male participants (n = 18) contained
significantly higher levels of IL-6 compared to females (n = 42)
(p = 0.00); 2.8262.23 vs. 1.0360.91 pg/mL respectively. Howev-
er when the data was stratified into age groups, this observation
did not remain statistically significant (Table 1). No significant
differences were observed between males and females for any
other markers of inflammation, oxidative damage or [NAD(H)].
Discussion
Considerable evidence now indicates that both inflammation
and oxidative stress contribute to the development of various
neuropathologies including Alzheimer’s and Parkinson’s disease
[14,16,23]. While age is the major risk factor for the development
of most neurodegenerative disorders it has yet to be confirmed if
oxidative stress and inflammation increase during normal brain
aging in humans. To our knowledge this is the first study to show
that both oxidative damage and inflammation increase after the
age of 45 in the central nervous system (CNS) of relatively healthy
humans. In this study we report that the CSF of participants aged
over 45 years contained statistically higher amounts of the
oxidative damage marker F2-isoprostane and the inflammatory
cytokine IL-6. Those aged over 45 years also tended to have
increased CSF levels of the DNA damage marker 8-OHdG. These
data are consistent with previous results from both our laboratory
and others showing that DNA and lipid oxidation increase with
age in multiple organs, including the brain in animals
[11,12,24,43]. While limited research has been conducted within
the CNS of living humans, an age related accumulation in markers
of both oxidative damage (8-OHdG) and inflammation (IL-6) has
been previously reported in postmortem brain tissue [9,44].
It is well established, that oxidative DNA damage activates the
NAD-dependent DNA repair enzyme, PARP, which is involved in
base excision repair [45]. Utilizing unexposed human skin, our
laboratory has previously shown that that PARP activity increases
with age and correlates with NAD+ depletion [46]. In the present
study we investigated whether levels of CSF NAD(H) were also
associated with age and report for the first time that [NAD(H)]
does decline with age in the CNS of healthy humans. As expected
an inverse trend between CSF [NAD(H)] and markers of central
DNA (8-OHdG) and lipid (F2-isoprostanes) oxidative damage was
also observed. In addition, as would be predicted, after controlling
for age, increased CSF total antioxidant capacity was significantly
correlated with higher CSF levels of NAD(H).
Adequate levels of NAD(H) are required to maintain normal
cellular functions. In addition to its role in cellular energy
metabolism there are several enzymes, in addition to PARP, that
use the oxidized form, NAD+ as the sole substrate for their
activities [25–27]. Notably SIRT1, a member of a highly
conserved family of histone deacetylases modulates key transcrip-
tion factors such as FOXO and pro-apoptotic p53, and is thought
to play a central role in cell longevity and aging [47,48]. As both
PARP and SIRT1 compete for the same intracellular pool of
NAD+ it has been suggested that depletion of NAD+ results in
reduced SIRT1 deacetylase activity [24,49]. Further PARP over-
activation has been shown to reduce ATP production due to
NAD+ depletion resulting in neuronal death [29–31]. The theory
that excessive NAD+ depletion facilitates cell death is supported by
observations in rodent models of brain ischemia and Alzheimer’s
Table 1. Differences in selected CSF markers according to age and gender.
#45 years, mean (6 SD) .45 years, mean (6 SD)
Characteristic/Test Male+Female Male Female Male+Female Male Female
(n) 34 1 33 36 19 17
Average Age (years) 34 (5) 45 34 (5) 71 (8) 70 (8) 73 (9)
CSF F2-Isoprostanes (pmol/L) 395.09(34.04) 405.95 394.57 (34.79) 417.49 (34.39)* 422.08 (39.45) 413.23 (29.81)
CSF 8-OHdG (ng/mL) 0.45 (0.09) . 0.45 (0.09) 0.52 (0.13) 0.53 (0.16) 0.51 (0.12)
CSF IL-6 (pg/mL) 0.71 (0.43) 1.25 0.69 (0.43) 2.37 (1.93)** 2.91 (2.26) 1.71 (1.23)**
CSF TAC (nmol/mg protein) 1.49 (0.51) . 1.49 (0.51) 0.90 (0.28)** 0.87 (0.30) 0.98 (0.30)*
CSF [NAD(H)] (mg/mL) 88.59 (21.07) 42.68 89.98 (19.75) 75.88 (30.14)* 78.64 (34.38) 73.13 (25.99)*
Plasma [NAD(H)] (mg/mL) 374.93 (102.94) 471.18 369.26 (103.18) 345.01 (94.95) 362.02 (38.26) 332.26 (79.98)
Due to small sample volume, some tests have one or more missing data. Comparisons made using the Independent T Test or Mann-Whitney U Test.
*p#0.05 compared to #45 years,
**p#0.001 compared to #45 years.
doi:10.1371/journal.pone.0085335.t001
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disease where significantly reduced levels of total cellular NAD+
occur prior to neuronal death [50–52]. Adequate NAD+ levels are
therefore required to maintain cellular energy and robust SIRT1
activity. However further functional studies are required to
determine the level of biochemical impact the relatively modest
(,14%) decrease in NAD(H) levels would have on cell metabo-
lism.
While the physiologic and pathologic importance of NAD+/
NADH dependant mechanisms’ in both the central nervous
system and periphery is apparent, it was not previously known
whether peripheral stores of NAD(H) influence central NAD(H)
levels. This study is the first to show a positive correlation between
matched CSF and plasma NAD(H) levels in a healthy human
cohort. This is consistent with a previous study by Rex and
colleagues (2002) who observed that NAD(H) in both its oxidized
and reduced forms is capable of crossing the blood brain barrier in
rats [53]. While evidence indicates that the brain is capable of
independently synthesizing NAD+ [54,55], results from the present
study suggest that NAD(H) levels in the brain are potentially
influenced by peripheral NAD(H) levels and consequently lifestyle
choices that affect the peripheral NAD(H) pool.
Although age is the major risk factor for the development of
most neurodegenerative disorders [32,33], a number of lifestyle
choices can increase central oxidative damage and inflammation
and thereby promote disease. In this cohort we observed that
consumption of less than half a glass or more of alcohol per day
was associated with a statistically significant increase in CSF levels
of the inflammatory cytokine IL-6. While excessive alcohol
consumption is generally agreed to cause alteration in brain
structure, function and loss of brain mass [56,57], the effect of low
to moderate alcohol consumption on brain health is still debated
within the literature. Some authors suggest that low to moderate
alcohol consumption may improve cognitive functioning and even
reduce the risk of Alzheimer’s disease [58,59]. In contrast to these
largely epidemiological studies, a meta-analysis conducted by
Verbaten (2009) assessing the effects of alcohol consumption on
brain integrity, determined by both MRI and cognitive perfor-
mance, concluded that the consumption of even light to moderate
doses of alcohol lead to shrinkage of the brain and to decreases in
grey matter volume [60].
The suggested pathways by which alcohol may damage the
brain are numerous and include, but are not limited to, disruption
of neural cell adhesion molecules [61–63], promotion of endo-
plasmic reticulum protein misfolding [64], neuronal hypersensi-
Figure 1. Inter-correlation between CSF NAD(H), oxidative
damage and inflammatory markers. (A) Positive association
between CSF 8 OHdG and CSF total antioxidant capacity. A
significant positive association was observed between CSF 8 OHdG and
log total antioxidant capacity (TAC) (p = 0.05, n = 37). Comparisons were
made using multiple linear regression controlling for age. (B) Positive
association between CSF 8 OHdG and CSF F2 Isoprostane
levels. A significant positive association was observed between CSF
8 OHdG and F2 Isoprostane levels (p = 0.01, n = 34). Comparisons were
made using multiple linear regression controlling for age. (C) Inverse
association between CSF [NAD(H)] and CSF F2 Isoprostane
levels. A significant inverse association was observed between CSF
[NAD(H)] and F2 Isoprostane levels (p = 0.02, n = 48). Comparisons were
made using the Pearson correlation coefficient and multiple linear
regression controlling for age.
doi:10.1371/journal.pone.0085335.g001
Figure 2. Positive association between plasma and CSF NAD(H)
levels. A significant positive relationship was observed between
plasma and CSF NAD(H) concentrations (p = 0.03, n = 38). An increase
of one mg/mL in plasma [NAD(H)] was associated with a 0.11 mg/mL
increase in CSF [NAD(H)]. Comparisons were made using multiple linear
regression controlling for age.
doi:10.1371/journal.pone.0085335.g002
CSF Oxidative Stress, Inflammation and [NAD(H)]
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tivity to excitotoxic insults [65], reduction of endogenous
antioxidants [66], and increased free radical damage to both
blood brain barrier endothelial cells as well as neurons [67,68].
Consistent with our findings, others have also shown that alcohol,
even at low/moderate concentrations, can act as a ligand for toll
like receptor 4 (TLR4), stimulating the mitogen-activated protein
kinases (MAPKs) and the transcription factor NF-kB pathways,
leading to the production of nitric oxide and inflammatory
cytokines [69,70].
We also report for the first time an inverse relationship between
alcohol consumption and CSF [NAD(H)]. Specifically the CSF of
participants who consumed greater than one glass of alcohol per
day had significantly lower levels of NAD(H) compared to those
who did not drink alcohol. While research investigating the effect
of alcohol on NAD(H) is scarce our results are consistent with a
very early report by McElfresh and McDonald (1983) who also
observed in Drosophila that NAD+ levels decrease by at least 20% in
response to ethanol stress [71]. Additionally recent data from our
laboratory (unpublished) indicates that acute ethanol exposure
(10 mM, equivalent to a blood alcohol of 0.05%) decreases
intracellular [NAD(H)] in cultured human primary astrocytes
(brain metabolic support cells) by as much as 64% within 30
minutes in conjunction with an increase in oxidative damage and
PARP activity. By increasing CNS inflammation and oxidative
damage, alcohol consumption may stimulate PARP over-activa-
tion and subsequently decrease central NAD(H) levels promoting
senescence and neurodegeneration.
While the observations reported in this study are statistically
valid it is recognized that these associations have been obtained
from a modest number of participants (38 plasma/CSF matched
and 70 CSF). Though both genders were well represented in the
older age groups, due to the difficulty in obtaining CSF samples
from essentially healthy individuals greater numbers of females
were represented in the younger age range. The disproportion-
ately low number of younger male participants, as well as the small
number of participants for which alcohol consumption data was
available, prevented a comprehensive analysis on how gender may
influence our findings. Self-reported alcohol consumption was also
relied upon in this study and may have introduced some error into
our analysis. However while such error may cause the levels of
alcohol reported to slightly differ from the number of glasses
actually consumed, it is unlikely to significantly affect the rank
order of participants. Finally the restricted volume of sample
collected as part of this study limited our analytical profile negating
comparisons with other important molecular species such as the
range of anti-inflammatory cytokines. Future studies overcoming
these limitations are required to verify the consistency of our
observations.
Conclusion
An extensive body of evidence indicates that oxidative stress and
inflammation play a central role in the physiology of aging.
However, comparatively limited data are available to verify
whether these processes also contribute to normal aging within the
brain. This study reports for the first time a potential link between
aging, increased oxidative stress, inflammation and alcohol
consumption and a decline in the essential pyridine nucleotide
[NAD(H)], in the CSF of a healthy human population. We also
provide evidence of a relationship between peripheral and central
NAD(H) stores.
Taken together these data suggest a progressive age associated
increase in oxidative damage, inflammation and reduced NAD(H)
in the brain which may be exacerbated by certain lifestyle choices
such as regular alcohol consumption.
As reduced NAD(H) levels impact at least PARP and SIRT1
activity the observed decrease in NAD(H) availability within the
aging brain may facilitate cell metabolic and genomic instability
increasing an individuals’ susceptibility to degenerative disease.
However further follow-up of the participants characterized in this
study is required to confirm this hypothesis.
Figure 3. Association between alcohol consumption and CSF
(A) [NAD(H)] (B) IL-6 levels. (A) Alcohol consumption is
associated with decreased levels of CSF NAD(H). Participants
who consumed zero (n = 32), .0–1 (n = 14) and .1 (n = 8) standard
alcoholic drinks per day were found to contain significantly different
levels of CSF NAD(H) (p = 0.02). Specifically the CSF of participants who
consumed .1 standard drink of alcohol per day contained significantly
lower levels of NAD(H) compared to those who reported consuming
zero drinks per day; 62.39619.93 vs. 86.93625.32 mg/mL respectively
(p,0.05). Comparisons were made using the Kruskal-Wallis with Dunn’s
post-hoc test. Error bars represent 95% confidence intervals. (B)
Alcohol consumption is associated with increased levels of CSF
IL-6. A significant increase in CSF IL-6 was observed in participants who
drank .1 (p,0.05) and .0–1 (p,0.05) standard alcoholic drinks per
day compared to those who drank zero; 2.1261.28, 2.2561.66 vs.
1.1661.67 pg/mL respectively. Comparisons were made using the
Kruskal-Wallis with Dunn’s post-hoc test. Error bars represent 95%
confidence intervals.
doi:10.1371/journal.pone.0085335.g003
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